Literature DB >> 29110080

Pemphigus trigger factors: special focus on pemphigus vulgaris and pemphigus foliaceus.

Soheil Tavakolpour1,2.   

Abstract

Pemphigus is a general term for a rare group of autoimmune diseases which result in the formation of blisters on the skin and oral cavity. Although there is no way to prevent autoimmune diseases, some factors may trigger pemphigus initiation in susceptible individuals or be exacerbated in affected patients. Recognition of these triggers, based on the latest studies and experiences is essential and should be updated every few years. In this study, several triggers, including different drugs and treatments, diseases, vaccines, genetic factors, nutrients, micronutrients, pregnancy, stress, and various other triggers have been discussed. Some possible triggers, such as blood antigens and the effect of seasons have also been discussed briefly. Moreover, some protective factors against pemphigus have been reviewed. Considering the molecular mechanism of pemphigus and immune response alteration during this disease, some possible triggers have been suggested and discussed. Although those triggers may be a real threat, more studies are needed to support these hypotheses.

Entities:  

Keywords:  Drug-induced pemphigus; Pemphigus; Pemphigus foliaceus; Pemphigus trigger; Pemphigus vulgaris

Mesh:

Substances:

Year:  2017        PMID: 29110080     DOI: 10.1007/s00403-017-1790-8

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  11 in total

1.  Experience in the diagnosis and treatment of a drug-induced pemphigus.

Authors:  Pei Yang Yuan; Min Qiu; Zi Xin Wan; Lu Jiang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-12-01

2.  New-onset pemphigus foliaceus following SARS-CoV-2 infection and unmasking multiple sclerosis: A case report.

Authors:  Fatemeh Mohaghegh; Parvaneh Hatami; Arezoo Refaghat; Mohammadjavad Mehdizadeh; Zeinab Aryanian; Nessa Aghazadeh Mohandesi; Zeinab Mohseni Afshar
Journal:  Clin Case Rep       Date:  2022-06-03

3.  Genetic Associations and Differential mRNA Expression Levels of Host Genes Suggest a Viral Trigger for Endemic Pemphigus Foliaceus.

Authors:  Valéria Bumiller-Bini Hoch; Ana Flávia Kohler; Danillo G Augusto; Sara Cristina Lobo-Alves; Danielle Malheiros; Gabriel Adelman Cipolla; Angelica Beate Winter Boldt; Karin Braun-Prado; Michael Wittig; Andre Franke; Claudia Pföhler; Margitta Worm; Nina van Beek; Matthias Goebeler; Miklós Sárdy; Saleh Ibrahim; Hauke Busch; Enno Schmidt; Jennifer Elisabeth Hundt; Patrícia Savio de Araujo-Souza; Maria Luiza Petzl-Erler
Journal:  Viruses       Date:  2022-04-23       Impact factor: 5.818

4.  Pemphigus vulgaris after SARS-CoV-2 vaccination: A case with new-onset and two cases with severe aggravation.

Authors:  Gulsen Akoglu
Journal:  Dermatol Ther       Date:  2022-03-15       Impact factor: 3.858

5.  The potential roles of herpesvirus and cytomegalovirus in the exacerbation of pemphigus vulgaris.

Authors:  Fariba Mohammadi; Zahra Khalili; Sayed Mahdi Marashi; Amirhoushang Ehsani; Maryam Daneshpazhooh; Majid Teymoori-Rad; Kamran Balighi; Ahmad Nejati; Shohreh Shahmahmoodi; Shima Izadidakhrabadi; Hamidreza Mahmoudi; Pedarm Noormohammadpour
Journal:  Dermatol Pract Concept       Date:  2018-10-31

6.  De novo severe pemphigus vulgaris following SARS-CoV-2 vaccination with BBIBP-CorV.

Authors:  Zahra Saffarian; Rana Samii; Alireza Ghanadan; Hassan Vahidnezhad
Journal:  Dermatol Ther       Date:  2022-03-20       Impact factor: 3.858

Review 7.  Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.

Authors:  Ajeet Singh; Sujana J Bharadwaj; Anju G Chirayath; Satyaki Ganguly
Journal:  J Cosmet Dermatol       Date:  2022-04-09       Impact factor: 2.189

8.  New onset pemphigus foliaceus following AstraZeneca COVID-19 vaccination.

Authors:  Mina Almasi-Nasrabadi; Radha S Ayyalaraju; Ashish Sharma; Somaia Elsheikh; Shanti Ayob
Journal:  J Eur Acad Dermatol Venereol       Date:  2022-08-14       Impact factor: 9.228

Review 9.  Patient Quality of Life Improvement in Bullous Disease: A Review of Primary Literature and Considerations for the Clinician.

Authors:  Jessica J Padniewski; Rob L Shaver; Brittney Schultz; David R Pearson
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-01-10

10.  The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy.

Authors:  Federico Bardazzi; Diego Abbenante; Federica Filippi; Lidia Sacchelli; Camilla Loi
Journal:  Dermatol Ther       Date:  2021-07-14       Impact factor: 3.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.